September 1, 2013New England Journal of Medicine
The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?
Authors
Discussion
Loading...
Member takes
Implication
Methodological review reveals efficiency benefits of randomized registry trials, indicating that data quality concerns must be resolved before widespread clinical adoption.
Key Points
- To evaluate the feasibility, efficiency, and methodological challenges of integrating randomized clinical trials into existing disease registries.
- Methodological review evaluating the framework of registry-based randomized clinical trials.
- Assessment of structural advantages in trial efficiency and cost reduction against potential limitations in registry data integrity.
- Registry-based randomized designs provide substantial reductions in administrative burden, trial expense, and operational complexity compared to standard trial designs.
- Widespread clinical implementation remains limited by concerns regarding the completeness, accuracy, and overall quality of underlying registry data sets.
Cite This Study
Lauer et al. (2013) studied this question.